Fahey Tom, Schroeder Knut
Tayside Centre for General Practice, University of Dundee, Dundee.
Br J Gen Pract. 2004 Sep;54(506):695-702.
This article describes recent developments in cardiology and cardiovascular disease that are likely to be relevant to primary healthcare professionals and their patients. The following subject areas are covered: Primary prevention: recent developments in pharmaco-logical interventions, drug interactions, and drugs that are likely to cause harm; cardiovascular risk estimation and shared decision making with patients; and new developments in 24-hour ambulatory blood pressure monitoring. Secondary prevention: new models of care, including nurse-led care for the provision of hypertension and secondary prevention clinics; new drugs for the treatment of angina and myocardial infarction; ambulatory electrocardiography for the diagnosis of arrhythmias in primary care; and new developments in the treatment of atrial fibrillation - direct thrombin inhibitors and implantable devices. Tertiary prevention: recent developments in cardiac rehabilitation; recent evidence concerning revascularisation procedures and appropriateness criteria for referral; and implantable defibrillators.
本文介绍了心脏病学和心血管疾病的最新进展,这些进展可能与初级医疗保健专业人员及其患者相关。涵盖以下主题领域:一级预防:药物干预、药物相互作用以及可能造成危害的药物的最新进展;心血管风险评估以及与患者的共同决策;24小时动态血压监测的新进展。二级预防:新的护理模式,包括由护士主导的高血压护理和二级预防诊所;治疗心绞痛和心肌梗死的新药;基层医疗中用于诊断心律失常的动态心电图;以及心房颤动治疗的新进展——直接凝血酶抑制剂和植入式装置。三级预防:心脏康复的最新进展;关于血运重建程序的最新证据以及转诊的适当标准;以及植入式除颤器。